Intrauterine instillation of prostaglandin F2ALPHA IN EARLY PREGNANCY.
Intrauterine PGF2alpha (5mg) was administered for termination of early pregnancy in 14 healthy volunteers. With 11 complete abortions, the efficiency rate of this technique is below conventional methods. In addition, the incidience of infection was high occuring in 12 out of 14 subjects. Because of persistent bleeding, six patients underwent a dilatation and curettage. Other significant side effects included transient hypertension, pain, nausea and restlessness. In the patients with a complete abortion, the mean plasma progesterone concentration fell 37% after 8 hours post PGF2alpha instillation and 90iod and 75% over the next 14 days.
D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D006063:Chorionic Gonadotropin / Q000652:urine; D004958:Estradiol / Q000097:blood; D005260:Female; D006801:Humans; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011460:Prostaglandins F / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D006063:Chorionic Gonadotropin; D011460:Prostaglandins F; D011374:Progesterone; D004958:Estradiol